Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeff Settleman

Showing results (31-40 of 65) with videos related to

Pageof 7
Sort By:
Cancer Cell|May 30, 2009
A gene expression signature associated with "K-Ras addiction" reveals regulators of EMT and tumor cell survivalAnurag Singh, Patricia Greninger, Daniel Rhodes, et al.
Molecular Cancer Therapeutics|June 17, 2017
Cotargeting of MEK and PDGFR/STAT3 Pathways to Treat Pancreatic Ductal AdenocarcinomaNisebita Sahu, Emily Chan, Felix Chu, et al.
Journal of Cell Science|September 29, 2005
p190 Rho-GTPase activating protein associates with plexins and it is required for semaphorin signallingDavide Barberis, Andrea Casazza, Raffaella Sordella, et al.
Cell|February 21, 2012
TAK1 inhibition promotes apoptosis in KRAS-dependent colon cancersAnurag Singh, Michael F Sweeney, Min Yu, et al.
Oncotarget|September 7, 2014
Overcoming EMT-associated resistance to anti-cancer drugs via Src/FAK pathway inhibitionCatherine Wilson, Katrina Nicholes, Daisy Bustos, et al.
Nature Communications|August 4, 2016
Functional screening implicates miR-371-3p and peroxiredoxin 6 in reversible tolerance to cancer drugsNisebita Sahu, Jean-Philippe Stephan, Darlene Dela Cruz, et al.
Cancer Research|May 10, 2014
The cancer stem cell marker aldehyde dehydrogenase is required to maintain a drug-tolerant tumor cell subpopulationDebasish Raha, Timothy R Wilson, Jing Peng, et al.
Molecular Cancer Therapeutics|February 1, 2017
Ras-MEK Signaling Mediates a Critical Chk1-Dependent DNA Damage Response in Cancer CellsHo-June Lee, Yi Cao, Victoria Pham, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2008
Increased prevalence of EGFR-mutant lung cancer in women and in East Asian populations: analysis of estrogen-related polymorphismsDaphne W Bell, Brian W Brannigan, Keitaro Matsuo, et al.
Science Signaling|September 14, 2017
Regulation of autophagy, NF-κB signaling, and cell viability by miR-124 in <i>KRAS</i> mutant mesenchymal-like NSCLC cellsAnita K Mehta, Kevin Hua, William Whipple, et al.
Pageof 7

Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
Cancer Cell|May 30, 2009
A gene expression signature associated with "K-Ras addiction" reveals regulators of EMT and tumor cell survivalAnurag Singh, Patricia Greninger, Daniel Rhodes, et al.
Molecular Cancer Therapeutics|June 17, 2017
Cotargeting of MEK and PDGFR/STAT3 Pathways to Treat Pancreatic Ductal AdenocarcinomaNisebita Sahu, Emily Chan, Felix Chu, et al.
Journal of Cell Science|September 29, 2005
p190 Rho-GTPase activating protein associates with plexins and it is required for semaphorin signallingDavide Barberis, Andrea Casazza, Raffaella Sordella, et al.
Cell|February 21, 2012
TAK1 inhibition promotes apoptosis in KRAS-dependent colon cancersAnurag Singh, Michael F Sweeney, Min Yu, et al.
Oncotarget|September 7, 2014
Overcoming EMT-associated resistance to anti-cancer drugs via Src/FAK pathway inhibitionCatherine Wilson, Katrina Nicholes, Daisy Bustos, et al.
Nature Communications|August 4, 2016
Functional screening implicates miR-371-3p and peroxiredoxin 6 in reversible tolerance to cancer drugsNisebita Sahu, Jean-Philippe Stephan, Darlene Dela Cruz, et al.
Cancer Research|May 10, 2014
The cancer stem cell marker aldehyde dehydrogenase is required to maintain a drug-tolerant tumor cell subpopulationDebasish Raha, Timothy R Wilson, Jing Peng, et al.
Molecular Cancer Therapeutics|February 1, 2017
Ras-MEK Signaling Mediates a Critical Chk1-Dependent DNA Damage Response in Cancer CellsHo-June Lee, Yi Cao, Victoria Pham, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2008
Increased prevalence of EGFR-mutant lung cancer in women and in East Asian populations: analysis of estrogen-related polymorphismsDaphne W Bell, Brian W Brannigan, Keitaro Matsuo, et al.
Science Signaling|September 14, 2017
Regulation of autophagy, NF-κB signaling, and cell viability by miR-124 in <i>KRAS</i> mutant mesenchymal-like NSCLC cellsAnita K Mehta, Kevin Hua, William Whipple, et al.
Pageof 7